Xuejun Wang
机构:South China Agricultural University, Shandong University of Traditional Chinese Medicine, University of Electronic Science and Technology of China, University of South Dakota, Medical College of Wisconsin, Fudan University, Tianjin Medical University Cancer Institute and Hospital, Foxconn (United States), Fudan University Shanghai Cancer Center, Qinghai Red Cross Hospital, Zhongshan Hospital, West Anhui University, Early Warning (United States), Shandong Center for Disease Control and Prevention · ORCID:0000-0001-5895-936X
发表论文 246 篇 · 总被引 3688 次 · h-index 33
代表论文
- Neutralizing antibody durability and SARS-CoV-2 infection in older adults six months after XBB-containing vaccine booster (2025 · Signal Transduction and Targeted Therapy · 被引 9)
- Engineered Ginseng‐Derived Nanovesicles with MCSP Targeting and Mitochondria‐Directed Prodrug Delivery for Synergistic Immunotherapy of Metastatic Melanoma (2025 · Advanced Functional Materials · 被引 3)
- Protective Effect of Red Yeast Rice on Immune Checkpoint Inhibitors‐Related Atherosclerotic Progression Through Inhibiting Macrophage Inflammatory Response and T Lymphocytes Infiltration (2026 · Phytotherapy Research · 被引 1)
- CHB‐Induced Immune Zonation Chaos Elicited LXRα‐mediated Lipid Metabolism Disorders in Kupffer Cells to Induce Cancer Stem Cell Formation (2025 · Advanced Science · 被引 1)
- Clinicopathological and Immunological Characteristics of Microsatellite Instability-High Gastric Cancer: A Retrospective Analysis of 4,599 Chinese Patients (2026 · Research Square)
- Succinate/SUCNR1 signaling amplifies macrophage inflammatory priming in atherosclerosis through the ERK–MYD88 axis (2026 · International Immunopharmacology)